Elimination of HCV in Russia: Barriers and Perspective

Hepatitis C virus (HCV) is highly prevalent in Russia, representing the largest pool of hepatitis C patients in Europe. Effective treatment regimens with direct-acting antivirals can achieve HCV cure in all patients; therefore, in 2016 the World Health Organization proposed eliminating hepatitis C a...

Descripción completa

Detalles Bibliográficos
Autores principales: Isakov, Vasily, Nikityuk, Dmitry
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9024583/
https://www.ncbi.nlm.nih.gov/pubmed/35458520
http://dx.doi.org/10.3390/v14040790
_version_ 1784690634491166720
author Isakov, Vasily
Nikityuk, Dmitry
author_facet Isakov, Vasily
Nikityuk, Dmitry
author_sort Isakov, Vasily
collection PubMed
description Hepatitis C virus (HCV) is highly prevalent in Russia, representing the largest pool of hepatitis C patients in Europe. Effective treatment regimens with direct-acting antivirals can achieve HCV cure in all patients; therefore, in 2016 the World Health Organization proposed eliminating hepatitis C as a public health threat by 2030. However, only a small number of countries are on track to meet the WHO’s hepatitis C elimination targets by 2030 due to many barriers in healthcare systems. This review focuses on a discussion about the epidemiology of HCV in Russia, the economic burden of HCV-related diseases, and treatment access with particular reference to the barriers for the elimination of HCV.
format Online
Article
Text
id pubmed-9024583
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-90245832022-04-23 Elimination of HCV in Russia: Barriers and Perspective Isakov, Vasily Nikityuk, Dmitry Viruses Review Hepatitis C virus (HCV) is highly prevalent in Russia, representing the largest pool of hepatitis C patients in Europe. Effective treatment regimens with direct-acting antivirals can achieve HCV cure in all patients; therefore, in 2016 the World Health Organization proposed eliminating hepatitis C as a public health threat by 2030. However, only a small number of countries are on track to meet the WHO’s hepatitis C elimination targets by 2030 due to many barriers in healthcare systems. This review focuses on a discussion about the epidemiology of HCV in Russia, the economic burden of HCV-related diseases, and treatment access with particular reference to the barriers for the elimination of HCV. MDPI 2022-04-11 /pmc/articles/PMC9024583/ /pubmed/35458520 http://dx.doi.org/10.3390/v14040790 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Isakov, Vasily
Nikityuk, Dmitry
Elimination of HCV in Russia: Barriers and Perspective
title Elimination of HCV in Russia: Barriers and Perspective
title_full Elimination of HCV in Russia: Barriers and Perspective
title_fullStr Elimination of HCV in Russia: Barriers and Perspective
title_full_unstemmed Elimination of HCV in Russia: Barriers and Perspective
title_short Elimination of HCV in Russia: Barriers and Perspective
title_sort elimination of hcv in russia: barriers and perspective
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9024583/
https://www.ncbi.nlm.nih.gov/pubmed/35458520
http://dx.doi.org/10.3390/v14040790
work_keys_str_mv AT isakovvasily eliminationofhcvinrussiabarriersandperspective
AT nikityukdmitry eliminationofhcvinrussiabarriersandperspective

Ejemplares similares